SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Five-year survival, quality of life, and individual costs of 303 consecutive medical intensive care patients—A cost-utility analysis
9 references·2 citing·31 second hop
Five-year survival, quality of life, and individual costs of 303 consecutive medical intensive care patients—A cost-utility analysis (2005)Five-year survival, quality of life, and …Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis* (2003)Cost-effectiveness of drotrec…Understanding Costs and Cost-Effectiveness in Critical Care: Report from the Second American Thoracic Society Workshop on Outcomes Research (2002)Understanding Costs and Cost-…Definitions and methods of cost assessment: an intensivist's guide (2002)Definitions and methods of co…Statistics notes: Cronbach's alpha: Table 1 (1997)Statistics notes: Cronbach's …Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations for reporting…Recommendations for Reporting Cost-effectiveness Analyses (1996)Recommendations for Reporting…German translation and psychometric testing of the SF-36 Health Survey: Preliminary results from the IQOLA project (1995)German translation and psycho…The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)The MOS 36-ltem Short-Form He…The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-item short-form he…Cost-Effectiveness Studies in the ICU: A Systematic Review* (2019)Cost-Effectiveness Studies in…Baseline quality of life before intensive care: A comparison of patient versus proxy responses (2010)Baseline quality of life befo…The MOS 36-Item Short-Form Health Survey (SF-36) (1993)The SF-36 Health Survey: Development and Use in Mental Health Research and the IQOLA Project (1994)Screening for mental health: validity of the MHI-5 using DSM-IV Axis I psychiatric disorders as gold standard (2001)Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation (2003)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)The Beaver Dam Health Outcomes study (1993)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany (2003)Linezolid for treatment of ventilator-associated pneumonia: A cost-effective alternative to vancomycin* (2004)When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature* (2006)Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Coefficient Alpha and the Internal Structure of Tests (1951)Methodological index for non‐randomized studies ( MINORS ): development and validation of a new instrument (2003)Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population (2008)Making sense of Cronbach's alpha (2011)Guidelines for pharmacoeconomic studies. (1992)Guidelines for Pharmacoeconomic Studies (1997)Markov Models in Medical Decision Making (1993)The Role of Cost-effectiveness Analysis in Health and Medicine (1996)Health Economic Methods: Cost-Minimization, Cost-Effectiveness, Cost-Utility, and Cost-Benefit Evaluations (2011)Short screening scales to monitor population prevalences and trends in non-specific psychological distress (2002)A Brief Measure for Assessing Generalized Anxiety Disorder (2006)Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report (2005)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)Relationship of subjective and objective social status with psychological and physiological functioning: Preliminary data in healthy, White women. (2000)SF-36 Health Survey Update (2000)An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ-4 (2009)
this work references cited by second hop

References

  • 1992The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.33,714 cited
  • 1992The MOS 36-ltem Short-Form Health Survey (SF-36)30,026 cited
  • 1997Statistics notes: Cronbach's alpha: Table 15,296 cited
  • 1996Recommendations for Reporting Cost-effectiveness Analyses1,146 cited
  • 1996Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine1,037 cited
  • 1995German translation and psychometric testing of the SF-36 Health Survey: Preliminary results from the IQOLA project763 cited
  • 2003Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis*225 cited
  • 2002Understanding Costs and Cost-Effectiveness in Critical Care: Report from the Second American Thoracic Society Workshop on Outcomes Research147 cited
  • 2002Definitions and methods of cost assessment: an intensivist's guide82 cited

Cited by

  • 2019Cost-Effectiveness Studies in the ICU: A Systematic Review*64 cited
  • 2010Baseline quality of life before intensive care: A comparison of patient versus proxy responses63 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work